Pneumocandin A4
| Internal ID | e302042b-c8cc-452a-a9c7-2a461812abcf |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | (10R,12S)-N-[(3S,6S,9S,11R,15S,18R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,25-dihydroxy-15-[(1R)-1-hydroxyethyl]-6-[2-(4-hydroxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C51H82N8O13/c1-6-29(2)24-30(3)14-11-9-7-8-10-12-16-41(65)54-36-15-13-23-53-49(70)44-45(66)31(4)27-59(44)51(72)43(39(63)26-40(52)64)57-47(68)37(22-19-33-17-20-34(61)21-18-33)55-48(69)38-25-35(62)28-58(38)50(71)42(32(5)60)56-46(36)67/h17-18,20-21,29-32,35-39,42-45,60-63,66H,6-16,19,22-28H2,1-5H3,(H2,52,64)(H,53,70)(H,54,65)(H,55,69)(H,56,67)(H,57,68)/t29-,30+,31-,32+,35+,36+,37-,38-,39+,42-,43-,44-,45-/m0/s1 |
| InChI Key | XYZCJMODJVDCJD-YIYGVBKCSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C51H82N8O13 |
| Molecular Weight | 1015.20 g/mol |
| Exact Mass | 1014.60013470 g/mol |
| Topological Polar Surface Area (TPSA) | 330.00 Ų |
| XlogP | 3.90 |
| Atomic LogP (AlogP) | 0.15 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 20 |
| (10R,12S)-N-[(3S,6S,9S,11R,15S,18R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,25-dihydroxy-15-[(1R)-1-hydroxyethyl]-6-[2-(4-hydroxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide |
| (10R,12S)-N-((3S,6S,9S,11R,15S,18R,24S,25S,26S)-3-((1R)-3-amino-1-hydroxy-3-oxopropyl)-11,25-dihydroxy-15-((1R)-1-hydroxyethyl)-6-(2-(4-hydroxyphenyl)ethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo(22.3.0.09,13)heptacosan-18-yl)-10,12-dimethyltetradecanamide |
| (10R,12S)-N-((3S,6S,9S,11R,15S,18R,24S,25S,26S)-5,8,11,17,23,25-Hexahydroxy-3-((1R)-1-hydroxy-2-(C-hydroxycarbonimidoyl)ethyl)-15-((1R)-1-hydroxyethyl)-6-(2-(4-hydroxyphenyl)ethyl)-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo(22.3.0.0,)heptacosa-4,7,16,22-tetraen-18-yl)-10,12-dimethyltetradecanimidate |
| (10R,12S)-N-[(3S,6S,9S,11R,15S,18R,24S,25S,26S)-5,8,11,17,23,25-Hexahydroxy-3-[(1R)-1-hydroxy-2-(C-hydroxycarbonimidoyl)ethyl]-15-[(1R)-1-hydroxyethyl]-6-[2-(4-hydroxyphenyl)ethyl]-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidate |
| RefChem:174958 |
| CHEBI:214403 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7676 | 76.76% |
| Caco-2 | - | 0.8624 | 86.24% |
| Blood Brain Barrier | - | 0.7750 | 77.50% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.3790 | 37.90% |
| OATP2B1 inhibitior | - | 0.8610 | 86.10% |
| OATP1B1 inhibitior | + | 0.8216 | 82.16% |
| OATP1B3 inhibitior | + | 0.9248 | 92.48% |
| MATE1 inhibitior | - | 0.8600 | 86.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9332 | 93.32% |
| P-glycoprotein inhibitior | + | 0.7396 | 73.96% |
| P-glycoprotein substrate | + | 0.8909 | 89.09% |
| CYP3A4 substrate | + | 0.7354 | 73.54% |
| CYP2C9 substrate | - | 0.6095 | 60.95% |
| CYP2D6 substrate | - | 0.7762 | 77.62% |
| CYP3A4 inhibition | - | 0.9220 | 92.20% |
| CYP2C9 inhibition | - | 0.9410 | 94.10% |
| CYP2C19 inhibition | - | 0.9197 | 91.97% |
| CYP2D6 inhibition | - | 0.8637 | 86.37% |
| CYP1A2 inhibition | - | 0.9549 | 95.49% |
| CYP2C8 inhibition | + | 0.8105 | 81.05% |
| CYP inhibitory promiscuity | - | 0.9752 | 97.52% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.6375 | 63.75% |
| Eye corrosion | - | 0.9897 | 98.97% |
| Eye irritation | - | 0.8992 | 89.92% |
| Skin irritation | - | 0.7828 | 78.28% |
| Skin corrosion | - | 0.9257 | 92.57% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3680 | 36.80% |
| Micronuclear | + | 0.8500 | 85.00% |
| Hepatotoxicity | + | 0.5875 | 58.75% |
| skin sensitisation | - | 0.8846 | 88.46% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.6679 | 66.79% |
| Acute Oral Toxicity (c) | III | 0.6217 | 62.17% |
| Estrogen receptor binding | + | 0.8045 | 80.45% |
| Androgen receptor binding | + | 0.7293 | 72.93% |
| Thyroid receptor binding | + | 0.5431 | 54.31% |
| Glucocorticoid receptor binding | + | 0.5975 | 59.75% |
| Aromatase binding | + | 0.6073 | 60.73% |
| PPAR gamma | + | 0.7749 | 77.49% |
| Honey bee toxicity | - | 0.7137 | 71.37% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5400 | 54.00% |
| Fish aquatic toxicity | + | 0.7325 | 73.25% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.86% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.54% | 96.09% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 98.86% | 97.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.25% | 91.11% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 96.98% | 95.00% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 95.99% | 100.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.89% | 90.71% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.87% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.76% | 99.17% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 95.28% | 97.79% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.37% | 90.08% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 94.22% | 97.25% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 93.43% | 94.00% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 91.26% | 97.03% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 91.11% | 96.33% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.61% | 82.69% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.50% | 93.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 88.98% | 98.59% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 88.62% | 95.93% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.50% | 95.89% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 87.80% | 92.86% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 87.77% | 100.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 87.55% | 94.66% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 86.95% | 94.45% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 86.73% | 97.64% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.46% | 93.56% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 86.46% | 97.23% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.84% | 98.75% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 84.53% | 92.50% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 84.06% | 98.05% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 83.84% | 98.03% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 83.51% | 96.11% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 81.70% | 82.38% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 81.11% | 96.47% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 81.01% | 96.61% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.77% | 89.00% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 80.32% | 92.88% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 80.17% | 96.37% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.04% | 97.14% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139588477 |
| LOTUS | LTS0046049 |
| wikiData | Q105344752 |